Results 1 to 10 of about 864 (101)
In Vitro Activity of Thienamycin [PDF]
Antimicrobial Agents and Chemotherapy, 1978 The in vitro activity of thienamycin was tested against 135 aerobic and anaerobic bacteria. The compound was highly active against resistant gram-negative bacilli and penicillin-resistant Straphylococcus aureus . The antianaerobic spectrum of the drug seemed to be comparable to that of metronidazole.
F P, Tally, N V, Jacobus, S L, Gorbach
openaire +2 more sources
In vitro activity of N-formimidoyl thienamycin (MK0787), a crystalline derivative of thienamycin [PDF]
Antimicrobial Agents and Chemotherapy, 1980 N-Formimidoyl thienamycin (MK0787) is a derivative of thienamycin, a unique, new beta-lactam antibiotic. Its activity against 285 aerobic and facultatively anaerobic clinical isolates was compared with the activities of cephalothin, ampicillin, penicillin G, ticarcillin, and tobramycin.
V W, Horadam +3 more
openaire +2 more sources
Synthese einer chiralen Thienamycin-Vorstufe / Synthesis of a Chiral Thienamycine Intermediate [PDF]
Zeitschrift für Naturforschung B, 1987 Abstract A key intermediate of Kametani’s total synthesis of racemic thienamycine has now been prepared in chiral form via a 1.3-dipolar cycloadduct of a chiral nitrone and benzyl crotonate.
Hubert Martin, Rudolf Herrmann, Ivar Ugi
openaire +1 more source
Antibacterial activities of a new stabilized thienamycin, N-formimidoyl thienamycin, in comparison with other antibiotics [PDF]
Antimicrobial Agents and Chemotherapy, 1980 The in vitro activity of a new crystalline derivative of thienamycin, N-formimidoyl thienamycin (MK0787), was tested against 46 laboratory reference strains and 2,158 clinical isolates of gram-positive and -negative bacteria, including anaerobes, and compared with cefoxitin, cefaxolin, carbenicillin, and amikacin.
T, Kesado, T, Hashizume, Y, Asahi
openaire +2 more sources
N-formimidoyl thienamycin (MK0787): in vitro study [PDF]
Antimicrobial Agents and Chemotherapy, 1981 N-Formimidoyl thienamycin (MK0787) was compared in vitro with three other beta-lactam and two aminoglycoside antibiotics. It was second in activity only to cefotaxime against members of the Enterobacteriaceae and to amikacin against Pseudomonas species. It was the most active antibiotic against Staphylococcus aureus.
S, Shadomy, R S, May
openaire +2 more sources
Drug Design, Docking Studies And Synthesis of Certain Coumarinyl Azetidin-2-Ones and Evaluation of their Antimycobacterial Activity [PDF]
, 2016 Tuberculosis (TB) is the most common cause of the death from infectious disease world-wide, which affects mainly the poorest countries of the world. Cell wall of Mycobacterium tuberculosis includes peptidoglycans and complex lipids (mycolic acids) which ...
Arya, Raveendran
core
A formal total asymmetric synthesis of (+)-thienamycin
Tetrahedron: Asymmetry, 1995 Abstract Synthesis of an enantiomerically pure intermediate to (+)-thienamycin is presented: the pivotal reaction in this sequence is the highly diastereoselective Michael addition of a differentially protected lithium amide.
Davies, S, Hedgecock, C, Mckenna, J
openaire +2 more sources
In vitro activity of N-formimidoyl thienamycin (MK0787) [PDF]
Antimicrobial Agents and Chemotherapy, 1980 The in vitro activity of N-formimidoyl thienamycin (MK0787), a stable congener of thienamycin, was determined against 200 species of aerobic and 84 species of anaerobic bacteria. The compound was highly active against resistant gram-negative bacilli, penicillin-resistant Staphylococcus aureus, enterococci, and anaerobic bacteria.
F P, Tally, N V, Jacobus, S L, Gorbach
openaire +2 more sources
Methionine inhibition of thienamycin formation
Journal of Industrial Microbiology, 1988 Methionine interference in the formation of thienamycin byStreptomyces cattleya is due, to a major extent, to inhibition of enzyme activity.
Masaru Uyeda, Arnold L. Demain
openaire +1 more source
Application of affinity adsorption in thienamycin fermentation [PDF]
Applied Microbiology and Biotechnology, 1989 Many antibiotic fermentations are sensitive to high concentrations of their own product possibly due to product regulation and toxicity mechanisms. In this paper we discuss the feasibility of using affinity adsorption with biospecific ligands for in situ product removal to alleviate this problem.
Wang, Henry Y. +2 more
openaire +2 more sources